HIV Seropositivity

Infectious Diseases
0
Pipeline Programs
3
Companies
2
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Plus Therapeutics
1 program
Gundo SoN/A1 trial
Active Trials
NCT03795415UnknownEst. May 2021
Roche
RocheSTAVANGER NORWAY, Norway
1 program
Sports activityN/A1 trial
Active Trials
NCT03920969Completed1,169Est. Dec 2019

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Plus TherapeuticsGundo So
RocheSports activity

Clinical Trials (2)

Total enrollment: 1,169 patients across 2 trials

ANRS12373 GUNDO SO - Evaluation of an Empowerment Program for WLHIV in Mali

Start: May 2019Est. completion: May 2021
N/AUnknown
NCT03920969RocheSports activity

Sport and Self Esteem in Patients Living With HIV

Start: Feb 2019Est. completion: Dec 20191,169 patients
N/ACompleted

Related Jobs in Infectious Diseases

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space